Skip to main content

What causes infusion reactions to rituximab?

Medically reviewed by Leigh Ann Anderson, PharmD. Last updated on May 2, 2025.

Official Answer by Drugs.com

Rituximab infusion reactions are caused primarily by cytokine release in the body. Cytokines are immune system proteins in the body that help to fight infections but can cause an inflammatory response. Infusion reactions are a very common side effect of treatment with rituximab (Rituxan) and can occur in greater than 10% to 25% of patients across all approved uses for rituximab.

Although cytokines help fight infection, too many cytokines can be bad for the body. Sometimes these cytokine-related infusion-related reactions can be serious or lead to death. Be sure to tell your healthcare provider before you receive rituximab if you have ever had a severe reaction to Rituxan, rituximab or any rituximab product.

How do I recognize an infusion reaction to rituximab?

Infusion reactions can occur while you are receiving the rituximab infusion or within one day after you receive your treatment with Rituxan.

Tell your healthcare provider or get medical help right away (for example, call 911) if you get any of these symptoms during or after an infusion of rituximab:

Related: Review rituximab side effects (in more detail).

This is not all the information you need to know about rituximab (Rituxan) for safe and effective use and does not take the place of talking to your doctor about your treatment. Review the full rituximab information here, and discuss this information and any questions you have with your doctor or other health care provider.

Related questions

References

Read next

What is the success rate of Rituxan (rituximab) in patients with blood cancers?

In patients with hematological or blood cancers, including non-Hodgkin's lymphoma (NHL) and chronic lymphocytic leukemia (CLL), Rituxan’s success is measured in a number of ways. It is measured by looking at how long patients responded to treatment (median duration of response), how long they live without their disease progressing (progression-free survival) and how many patients respond to treatment (response rate).

Rituxan treatment improves outcomes in certain patients with NHL. Adding Rituxan alongside standard therapies enhances the response patients have to treatment and improves overall outcomes, including increasing the time patients live for without experiencing a progression of their disease.

Rituxan helps to improve overall survival in certain patients with CLL and also helps to increase the time patients live for without experiencing disease progression. Adding Rituxan alongside standard therapy enhances the response patients have to therapy. Continue reading

What is the success rate of Rituxan (rituximab) in rheumatoid arthritis?

Treatment with Rituxan (rituximab) successfully improves patient outcomes in patients with rheumatoid arthritis including reducing symptoms, reducing levels of fatigue and disability, and increasing health-related quality of life. It also slows the progression of structural damage in joints. Continue reading

What is the difference between Rituxan and Rituxan Hycela?

Rituxan (rituximab) is administered intravenously (IV), while Rituxan Hycela is given subcutaneously (SC). Continue reading

See also:

Related medical questions

Drug information

Related support groups